People · Operator
Named in public records as an officer, director or promoter · active 2017–2024 · AI / ML, Biotechnology, Retailing, Other, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Clinigence Holdings, Inc. | — | AI / ML | Growth/Late | $2.5B | $56.0M | 2022 |
| CytomX Therapeutics, Inc. | — | Biotechnology | Series C | $143.0M | $392.5M | 2023 |
| OrsoBio, Inc. | — | Biotechnology | Series C | $124.6M | $340.5M | 2023 |
| Oilex Holding LLC | — | Retailing | Series A | $9.6M | $32.6M | 2023 |
| Gmb Partners Llc | — | Retailing | Pre-Seed | $759K | $6.0M | 2017 |
| Bay Point Laboratories, Inc. | — | Other | Pre-Seed | $350K | $8.1M | 2019 |
| Listing Village LLC | — | Other Technology | Pre-Seed | $125K | $5.3M | 2017 |
Matthew Young at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Matthew Young on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| MICHAEL CHANG | 1 | 13 |
| Srinivas Akkaraju | 1 | 10 |
| Mihir Shah | 1 | 7 |
| Elaine Jones | 1 | 6 |
| Michael Bowen | 1 | 6 |
| Michael E. Pfau | 1 | 6 |
| Nancy Stagliano | 1 | 5 |
| Alan Heeger | 1 | 5 |
| Gary Wilcox | 1 | 4 |
| Warren Hosseinion | 1 | 4 |
| Cory Freedland | 1 | 3 |
| Frederick W Gluck | 1 | 3 |
| Elisa Luqman | 1 | 3 |
| Gangadhara Ganapati | 1 | 3 |
| Warren Hosseinionn | 1 | 3 |
| Elaine V. Jones | 1 | 3 |
| Sean McCarthy | 1 | 3 |
| Evan Rachlin | 1 | 3 |
| Muzammil Mansuri | 1 | 3 |
| Corbin Graves | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.